Latest Insider Transactions at Ge Health Care Technologies Inc. (GEHC)
This section provides a real-time view of insider transactions for Ge Health Care Technologies Inc. (GEHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GE HealthCare Technologies Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GE HealthCare Technologies Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 06
2024
|
Roland Rott CEO, Imaging |
SELL
Open market or private sale
|
Direct |
3,577
-12.83%
|
$307,622
$86.48 P/Share
|
|
Nov 05
2024
|
Roland Rott CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
9,698
-25.81%
|
$843,726
$87.65 P/Share
|
|
Nov 05
2024
|
Roland Rott CEO, Imaging |
BUY
Exercise of conversion of derivative security
|
Direct |
13,275
+26.11%
|
$531,000
$40.4 P/Share
|
|
Nov 05
2024
|
Philip Rackliffe CEO, AVS |
SELL
Open market or private sale
|
Direct |
900
-6.61%
|
$78,300
$87.63 P/Share
|
|
Nov 01
2024
|
Kenneth R. Stacherski Ch. Supply Chain & Serv. Ofc. |
SELL
Payment of exercise price or tax liability
|
Direct |
11,028
-28.96%
|
$959,436
$87.35 P/Share
|
|
Sep 01
2024
|
James Saccaro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,740
-2.76%
|
$146,160
$84.82 P/Share
|
|
Sep 01
2024
|
Roland Rott CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
685
-2.74%
|
$57,540
$84.82 P/Share
|
|
Sep 01
2024
|
Philip Rackliffe CEO, AVS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,553
-5.17%
|
$130,452
$84.82 P/Share
|
|
Sep 01
2024
|
Peter J Arduini President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,859
-5.18%
|
$492,156
$84.82 P/Share
|
|
Sep 01
2024
|
Frank R Jimenez GC & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,699
-2.24%
|
$142,716
$84.82 P/Share
|
|
Sep 01
2024
|
Taha Kass Hout Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,598
-2.37%
|
$134,232
$84.82 P/Share
|
|
Sep 01
2024
|
Kenneth R. Stacherski Ch. Supply Chain & Serv. Ofc. |
SELL
Payment of exercise price or tax liability
|
Direct |
458
-1.19%
|
$38,472
$84.82 P/Share
|
|
Aug 17
2024
|
H Lawrence Culp Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
291,053
-46.64%
|
$24,448,452
$84.8 P/Share
|
|
Aug 15
2024
|
Philip Rackliffe CEO, AVS |
BUY
Grant, award, or other acquisition
|
Direct |
2,051
+11.91%
|
-
|
|
Aug 15
2024
|
Roland Rott CEO, Imaging |
BUY
Grant, award, or other acquisition
|
Direct |
2,784
+10.03%
|
-
|
|
Aug 15
2024
|
Adam Y Holton Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,895
+44.86%
|
-
|
|
Aug 14
2024
|
Kenneth R. Stacherski Ch. Supply Chain & Serv. Ofc. |
SELL
Open market or private sale
|
Direct |
19,008
-33.03%
|
$1,577,664
$83.22 P/Share
|
|
Aug 07
2024
|
Thomas J. Westrick CEO, Patient Care Solutions |
SELL
Open market or private sale
|
Direct |
2,750
-13.57%
|
$220,000
$80.78 P/Share
|
|
Aug 03
2024
|
Kevin Michael O'Neill CEO, PDx |
SELL
Payment of exercise price or tax liability
|
Direct |
1,533
-6.38%
|
$127,239
$83.44 P/Share
|
|
Aug 03
2024
|
Roland Rott CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
1,630
-6.84%
|
$135,290
$83.44 P/Share
|
|
Jun 01
2024
|
James Saccaro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,998
-12.51%
|
$701,844
$78.0 P/Share
|
|
May 28
2024
|
Taha Kass Hout Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
3,300
-4.67%
|
$257,400
$78.7 P/Share
|
|
May 21
2024
|
Rodney F Hochman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,965
+20.02%
|
-
|
|
May 21
2024
|
Lloyd Howell Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,440
+28.83%
|
-
|
|
May 21
2024
|
Risa J Lavizzo Mourey Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,440
+25.67%
|
-
|
|
May 21
2024
|
Catherine A Lesjak Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,440
+28.83%
|
-
|
|
May 21
2024
|
Anne T Madden Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,965
+20.02%
|
-
|
|
May 21
2024
|
Tomislav Mihaljevic Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,440
+28.83%
|
-
|
|
May 21
2024
|
William J Stromberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,209
+20.42%
|
-
|
|
May 21
2024
|
Watkin Phoebe L. Yang Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,440
+28.83%
|
-
|
|
May 21
2024
|
H Lawrence Culp Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,440
+0.39%
|
-
|
|
May 15
2024
|
Jan Makela CEO, Imaging |
SELL
Open market or private sale
|
Direct |
66,955
-51.38%
|
$5,423,355
$81.54 P/Share
|
|
May 15
2024
|
Jan Makela CEO, Imaging |
BUY
Exercise of conversion of derivative security
|
Direct |
66,955
+17.16%
|
$4,753,805
$71.73 P/Share
|
|
May 13
2024
|
Jan Makela CEO, Imaging |
SELL
Open market or private sale
|
Direct |
20,227
-24.2%
|
$1,638,387
$81.57 P/Share
|
|
May 13
2024
|
Jan Makela CEO, Imaging |
BUY
Exercise of conversion of derivative security
|
Direct |
20,227
+19.49%
|
$1,274,301
$63.51 P/Share
|
|
May 01
2024
|
Frank R Jimenez GC & Corporate Secretary |
BUY
Open market or private purchase
|
Direct |
1,315
+1.71%
|
$99,940
$76.52 P/Share
|
|
Apr 01
2024
|
Roland Rott CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
837
-3.39%
|
$75,330
$90.91 P/Share
|
|
Mar 15
2024
|
General Electric CO |
SELL
Other acquisition or disposition
|
Direct |
14,000,000
-30.02%
|
-
|
|
Mar 01
2024
|
Roland Rott CEO, Imaging |
BUY
Grant, award, or other acquisition
|
Direct |
4,179
+14.49%
|
-
|
|
Mar 01
2024
|
Roland Rott CEO, Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
4,555
-6.44%
|
$414,505
$91.28 P/Share
|
|
Mar 01
2024
|
James Saccaro Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,245
+12.47%
|
-
|
|
Mar 01
2024
|
Kenneth R. Stacherski Ch. Supply Chain & Serv. Ofc. |
BUY
Grant, award, or other acquisition
|
Direct |
4,718
+7.58%
|
-
|
|
Mar 01
2024
|
Thomas J. Westrick CEO, Patient Care Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
2,965
+12.77%
|
-
|
|
Mar 01
2024
|
Thomas J. Westrick CEO, Patient Care Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
5,770
-6.92%
|
$525,070
$91.28 P/Share
|
|
Mar 01
2024
|
H Lawrence Culp Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
31,290
-4.79%
|
$2,847,390
$91.28 P/Share
|
|
Mar 01
2024
|
Peter J Arduini President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
36,399
+24.33%
|
-
|
|
Mar 01
2024
|
Peter J Arduini President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,444
-5.47%
|
$404,404
$91.28 P/Share
|
|
Mar 01
2024
|
Frank R Jimenez GC & Corporate Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
9,437
+11.25%
|
-
|
|
Mar 01
2024
|
Frank R Jimenez GC & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
11,284
-7.68%
|
$1,026,844
$91.28 P/Share
|
|
Mar 01
2024
|
Taha Kass Hout Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,976
+12.38%
|
-
|